Clinical Trial

Hyponatremia - Complications, Prognosis, Epidemiology in Finnish Tertiary Care

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Study Objectives and Hypothesis To determine the incidence of hyponatremia at TYKS and the factors associated with it. To assess how rapidly hyponatremia was corrected and how the rate of correction affected patient prognosis. To evaluate treatment modalities and their impact on patient prognosis, length of hospital stay, and their appropriateness in comparison with national and international treatment guidelines. To determine the incidence of osmotic demyelination at TYKS and the factors associated with it. To assess other complications and their clinical significance. To evaluate the impact of hyponatremia on various endpoints, such as mortality, length of hospital stay, seizures, confusion, and similar outcomes.
Trial Details
NCT Number NCT07430787
Lead Sponsor University of Turku
Conditions Hyponatremia, Osmotic Demyelination Syndrome, Alcohol Use Disorder
Enrollment 10,000 participants
Start Date 2023-09-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-24